Literature DB >> 23782145

BPC 157 and blood vessels.

Sven Seiwerth, Luka Brcic, Lovorka Batelja Vuletic, Danijela Kolenc, Gorana Aralica, Marija Misic, Anita Zenko, Domagoj Drmic, Rudolf Rucman, Predrag Sikiric1.   

Abstract

This review focuses on the described effects of BPC 157 on blood vessels after different types of damage, and elucidate by investigating different aspects of vascular response to injury (endothelium damage, clotting, thrombosis, vasoconstriction, vasodilatation, vasculoneogenesis and edema formation) especially in connection to the healing processes. In this respect, BPC 157 was concluded to be the most potent angiomodulatory agent, acting through different vasoactive pathways and systems (e.g. NO, VEGF, FAK) and leading to optimization of the vascular response followed, as it has to be expected, by optimization of the healing process. Formation of new blood vessels involves two main, partly overlapping mechanisms, angiogenesis and vasculogenesis. The additional mechanism of arteriogenesis is involved in the formation of collaterals. In conjunction with blood vessel function, we at least have to consider leakage of fluid/proteins/plasma, resulting in edema/exudate formation as well as thrombogenesis. Blood vessels are also strongly involved in tumor biology. In this aspect, we have neoangiogenesis resulting in pathological vascularization, vascular invasion resulting in release of metastatic cells and the phenomenon of homing resulting in formation of secondary tumors--metastases.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 23782145     DOI: 10.2174/13816128113199990421

Source DB:  PubMed          Journal:  Curr Pharm Des        ISSN: 1381-6128            Impact factor:   3.116


  22 in total

1.  Therapeutic potential of pro-angiogenic BPC157 is associated with VEGFR2 activation and up-regulation.

Authors:  Ming-Jer Hsieh; Hsien-Ta Liu; Chao-Nin Wang; Hsiu-Yun Huang; Yuling Lin; Yu-Shien Ko; Jong-Shyan Wang; Vincent Hung-Shu Chang; Jong-Hwei S Pang
Journal:  J Mol Med (Berl)       Date:  2016-11-15       Impact factor: 4.599

2.  Cyclophosphamide induced stomach and duodenal lesions as a NO-system disturbance in rats: L-NAME, L-arginine, stable gastric pentadecapeptide BPC 157.

Authors:  Krešimir Luetic; Mario Sucic; Josipa Vlainic; Zeljka Belosic Halle; Dean Strinic; Tinka Vidovic; Franka Luetic; Marinko Marusic; Sasa Gulic; Tatjana Turudic Pavelic; Antonio Kokot; Ranka Serventi Seiwerth; Domagoj Drmic; Lovorka Batelja; Sven Seiwerth; Predrag Sikiric
Journal:  Inflammopharmacology       Date:  2017-03-02       Impact factor: 4.473

3.  Novel Therapeutic Effects in Rat Spinal Cord Injuries: Recovery of the Definitive and Early Spinal Cord Injury by the Administration of Pentadecapeptide BPC 157 Therapy.

Authors:  Darko Perovic; Marija Milavic; Stjepan Dokuzovic; Ivan Krezic; Slaven Gojkovic; Hrvoje Vranes; Igor Bebek; Vide Bilic; Nenad Somun; Ivan Brizic; Ivan Skorak; Klaudija Hriberski; Suncana Sikiric; Eva Lovric; Sanja Strbe; Milovan Kubat; Alenka Boban Blagaic; Anita Skrtic; Sven Seiwerth; Predrag Sikiric
Journal:  Curr Issues Mol Biol       Date:  2022-04-27       Impact factor: 2.976

4.  Class side effects: decreased pressure in the lower oesophageal and the pyloric sphincters after the administration of dopamine antagonists, neuroleptics, anti-emetics, L-NAME, pentadecapeptide BPC 157 and L-arginine.

Authors:  Zeljka Belosic Halle; Josipa Vlainic; Domagoj Drmic; Dean Strinic; Kresimir Luetic; Mario Sucic; Maria Medvidovic-Grubisic; Tatjana Pavelic Turudic; Igor Petrovic; Sven Seiwerth; Predrag Sikiric
Journal:  Inflammopharmacology       Date:  2017-05-17       Impact factor: 4.473

5.  BPC 157 antagonized the general anaesthetic potency of thiopental and reduced prolongation of anaesthesia induced by L-NAME/thiopental combination.

Authors:  Mladen Zemba; Andrea Zemba Cilic; Igor Balenovic; Matija Cilic; Bozo Radic; Jelena Suran; Domagoj Drmic; Antonio Kokot; Vasilije Stambolija; Tamara Murselovic; Jadranka Katancic Holjevac; Sandra Uzun; Viktor Djuzel; Josipa Vlainic; Sven Seiwerth; Predrag Sikiric
Journal:  Inflammopharmacology       Date:  2015-11-13       Impact factor: 4.473

6.  Pentadecapeptide BPC 157 resolves Pringle maneuver in rats, both ischemia and reperfusion.

Authors:  Marijan Kolovrat; Slaven Gojkovic; Ivan Krezic; Dominik Malekinusic; Borna Vrdoljak; Katarina Kasnik Kovac; Tamara Kralj; Domagoj Drmic; Ivan Barisic; Katarina Horvat Pavlov; Andreja Petrovic; Antonija Duzel; Mario Knezevic; Ivan Mirkovic; Antonio Kokot; Alenka Boban Blagaic; Sven Seiwerth; Predrag Sikiric
Journal:  World J Hepatol       Date:  2020-05-27

7.  Pentadecapeptide BPC 157 Reduces Bleeding and Thrombocytopenia after Amputation in Rats Treated with Heparin, Warfarin, L-NAME and L-Arginine.

Authors:  Mirjana Stupnisek; Antonio Kokot; Domagoj Drmic; Masa Hrelec Patrlj; Anita Zenko Sever; Danijela Kolenc; Bozo Radic; Jelena Suran; Davor Bojic; Aleksandar Vcev; Sven Seiwerth; Predrag Sikiric
Journal:  PLoS One       Date:  2015-04-21       Impact factor: 3.240

Review 8.  Stable Gastric Pentadecapeptide BPC 157 and Wound Healing.

Authors:  Sven Seiwerth; Marija Milavic; Jaksa Vukojevic; Slaven Gojkovic; Ivan Krezic; Lovorka Batelja Vuletic; Katarina Horvat Pavlov; Andrea Petrovic; Suncana Sikiric; Hrvoje Vranes; Andreja Prtoric; Helena Zizek; Tajana Durasin; Ivan Dobric; Mario Staresinic; Sanja Strbe; Mario Knezevic; Marija Sola; Antonio Kokot; Marko Sever; Eva Lovric; Anita Skrtic; Alenka Boban Blagaic; Predrag Sikiric
Journal:  Front Pharmacol       Date:  2021-06-29       Impact factor: 5.810

9.  Pentadecapeptide BPC 157 shortens duration of tetracaine- and oxybuprocaine-induced corneal anesthesia in rats.

Authors:  Ivan Mirković; Tamara Kralj; Marin Lozić; Vasilije Stambolija; Josip Kovačević; Luka Vrdoljak; Mirna Zlatar; Kristina Milanović; Domagoj Drmić; Jurica Predović; Sanja Masnec; Matija Jurjević; Mladen Bušić; Sven Seiwerth; Antonio Kokot; Predrag Sikirić
Journal:  Acta Clin Croat       Date:  2020-09       Impact factor: 0.780

10.  Occlusion of the Superior Mesenteric Artery in Rats Reversed by Collateral Pathways Activation: Gastric Pentadecapeptide BPC 157 Therapy Counteracts Multiple Organ Dysfunction Syndrome; Intracranial, Portal, and Caval Hypertension; and Aortal Hypotension.

Authors:  Mario Knezevic; Slaven Gojkovic; Ivan Krezic; Helena Zizek; Dominik Malekinusic; Borna Vrdoljak; Hrvoje Vranes; Tamara Knezevic; Ivan Barisic; Katarina Horvat Pavlov; Domagoj Drmic; Miro Staroveski; Antonija Djuzel; Zoran Rajkovic; Toni Kolak; Ivica Kocman; Eva Lovric; Marija Milavic; Suncana Sikiric; Ante Tvrdeic; Leonardo Patrlj; Sanja Strbe; Antonio Kokot; Alenka Boban Blagaic; Anita Skrtic; Sven Seiwerth; Predrag Sikiric
Journal:  Biomedicines       Date:  2021-05-26
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.